Cargando…
Current drugs for HIV-1: from challenges to potential in HIV/AIDS
The human immunodeficiency virus (HIV) persists in latently infected CD4(+)T cells and integrates with the host genome until cell death. Acquired immunodeficiency syndrome (AIDS) is associated with HIV-1. Possibly, treating HIV/AIDS is an essential but challenging clinical goal. This review provides...
Autores principales: | Peng, Yuan, Zong, Yanjun, Wang, Dongfeng, Chen, Junbing, Chen, Zhe-Sheng, Peng, Fujun, Liu, Zhijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637376/ https://www.ncbi.nlm.nih.gov/pubmed/37954841 http://dx.doi.org/10.3389/fphar.2023.1294966 |
Ejemplares similares
-
Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges
por: Nie, Zhenyu, et al.
Publicado: (2022) -
The Challenge of Potential Drug–Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China
por: Xia, Huan, et al.
Publicado: (2020) -
Controlling the HIV/AIDS epidemic: current status and global challenges
por: Demberg, Thorsten, et al.
Publicado: (2012) -
A study of the top-cited studies on drug therapy for HIV
por: Tang, Jie, et al.
Publicado: (2022) -
Time to First Line Antiretroviral Therapy Adverse Drug Reaction and its Predictors Among Adult HIV/AIDS Patients on Treatment in Eastern Ethiopia
por: Weldesenbet, Adisu Birhanu, et al.
Publicado: (2022)